This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
- Ann M. Pellizzaro, MT(ASCP)
- Rita M. Heuertz, PhD, MT(ASCP)⇑
- Address for correspondence: Rita M. Heuertz, PhD, MT(ASCP), Clinical Laboratory Science Department, Doisy College of Health Sciences, Saint Louis University, 3437 Caroline Street, St. Louis, MO 63104-1111, 314-977-8610, FAX: 314-977-8503, heuertzr{at}slu.edu
Abstract
OBJECTIVE: Asthma is a chronic disease involving airway hyperresponsiveness. It was proposed that asthma/chronic shortness of breath elicit chronic systemic inflammation even in the absence of episodic events.
DESIGN: Volunteers completed questionnaires relevant to asthma and/or dyspnea and consented to C-reactive protein (CRP) quantitation. Subject groups were: control (no reported dyspnea) and asthma/shortness of breath [dyspnea] group.
SETTING: Studies were performed in the Saint Louis metropolitan area.
PARTICIPANTS: Participants consisted of volunteers aged 18-57. Inclusion criteria were good health, not pregnant, weight >110 pounds and absence of anti-inflammatory medicine use.
RESULTS: Serum CRP ranged from undetectable to 22,013 ng/mL. Mean results for asthmatic/dyspnea (n=22) and control (n=27) groups were 4,203±1,323 ng/mL and 1,741±467 ng/mL (p<0.05) respectively.
CONCLUSION: Individuals with asthma/asthma-like symptoms have chronic low levels of systemic inflammation despite the absence of episodic pulmonary events. Understanding chronic systemic inflammation relevant to asthma/asthma-like conditions may lead to design of targeted therapeutics.
ABBREVIATIONS: hsCRP = high sensitivity C-reactive protein
- © Copyright 2010 American Society for Clinical Laboratory Science Inc. All rights reserved.